ArticleFrontiers in oncology2025
Deep learning in assisting dermatologists in classifying basal cell carcinoma from seborrheic keratosis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Global trends and academic landscapes of AI applications in basal cell carcinoma research: a bibliometric analysis.Frontiers in oncology · 2026Review
- High-frequency ultrasound combined with superb microvascular imaging for differential diagnosis of basal cell carcinoma and seborrheic keratosis: a retrospective analysis with nomogram implementation.Frontiers in medicine · 2026Article
- Discriminating Basal Cell Carcinoma with Only 20 Dermoscopic Images: A Few-shot, Self-supervised Approach.Acta dermato-venereologica · 2025Article
- Enhancing dermatological diagnosis for differentiating actinic from seborrheic keratosis using deep learning model.Frontiers in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to evaluate the effectiveness of deep learning model in assisting dermatologists in classifying basal cell carcinoma (BCC) from seborrheic keratosis (SK). The goal was to assess whether AI-assisted diagnostics could improve accuracy, reduce misdiagnoses, and potentially enhance clinical outcomes. Methods: This prospective study included 707 patients with histopathologically confirmed BCC or SK as an internal dataset (validation cohort), along with 5572 patients from the ISIC public dataset as an external dataset (split into training and test cohort). The images were preprocessed and augmented before being fed into a deep learning model based on the CLIP ViT-B/16 architecture. The model's performance was assessed using the area under the receiver operating characteristic (ROC) curves (AUC). Two dermatologists, one with 3 years of experience and another with 15 years of experience, reviewed the cases before and after receiving the deep learning model's predictions. Net reclassification index (NRI) and integrated discrimination improvement (IDI), was used to quantify the improvement in reclassification performance. Results: The model achieved an AUC of 0.76 in the training cohort and 0.79 in the test cohort for differentiating between BCC and SK. In the validation cohort, the model demonstrated an AUC of 0.71. Dermatologist 1's AUC improved from 0.75 to 0.82 with deep learning model assistance, while Dermatologist 2's AUC increased from 0.79 to 0.82. NRI and IDI analysis revealed statistically significant improvements, with Dermatologist 1 showing a 18% improvement and Dermatologist 2 showing a 11% improvement. Additionally, attention mechanisms like Grad-CAM provided insights into the model's decision-making process, enhancing the interpretability of its predictions. Conclusion: The deep learning model demonstrated significant potential in aiding dermatologists in classifying BCC from SK.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.